Home » Stocks » NBY » Financials

NovaBay Pharmaceuticals, Inc. (NBY)

Stock Price: $0.655 USD 0.031 (5.02%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201120102009200820072006
Revenue9.936.6012.5118.2311.904.381.053.486.9511.029.7515.686.725.911.53
Revenue Growth50.54%-47.24%-31.39%53.23%171.56%315.65%-69.69%-49.95%-36.95%12.97%-37.81%133.32%13.68%285.71%-
Cost of Revenue3.971.741.502.782.461.260.490.160.01------
Gross Profit5.964.8611.0115.459.433.120.573.326.9411.029.7515.686.725.911.53
Selling, General & Admin12.1114.0818.6222.3519.0418.537.996.375.995.435.655.615.644.372.97
Research & Development0.290.180.260.411.375.739.4812.469.289.918.627.349.607.424.09
Operating Expenses12.3914.2618.8822.7620.4224.2617.4718.8315.2715.3414.2712.9415.2311.797.06
Operating Income-6.43-9.40-7.87-7.31-10.98-21.14-16.90-15.51-8.33-4.32-4.522.74-8.51-5.88-5.53
Other Expense / Income4.610.25-1.330.092.17-2.17-1.710.53-1.300.76-0.260.04-0.40-0.49-0.24
Pretax Income-11.03-9.65-6.54-7.40-13.15-18.97-15.19-16.04-7.03-5.08-4.262.70-8.11-5.39-5.29
Income Tax0.010.010.000.000.000.000.000.000.000.000.050.010.000.01-
Net Income-11.04-9.66-6.55-7.40-13.15-18.97-15.19-16.04-7.03-5.09-4.312.70-8.11-5.40-5.29
Shares Outstanding (Basic)35.0821.6416.9215.329.412.781.991.531.181.030.930.900.850.360.23
Shares Outstanding (Diluted)35.0821.6417.0615.329.412.781.991.531.181.030.930.920.850.360.23
Shares Change62.08%27.89%10.42%62.88%237.93%40.25%29.99%29.63%14.26%10.5%4.12%5.12%137.49%57.03%-
EPS (Basic)-0.31-0.48-0.39-0.48-1.40-6.82-7.65-10.51-5.97-4.93-4.503.00-9.50-15.00-23.00
EPS (Diluted)-0.31-0.48-0.46-0.48-1.40-6.82-7.65-10.51-5.97-4.93-4.503.00-9.50-15.00-23.00
Free Cash Flow Per Share-0.14-0.37-0.33-0.43-1.26-6.70-7.55-8.59-5.66-3.161.96-2.65-12.38-19.3119.17
Gross Margin60%73.7%88%84.7%79.3%71.2%53.9%95.3%99.9%100%100%100%100%100%100%
Operating Margin-64.7%-142.4%-62.9%-40.1%-92.3%-482.5%-1,603.8%-446.1%-119.9%-39.2%-46.3%17.5%-126.6%-99.4%-360.5%
Profit Margin-111.1%-158.9%-52.3%-40.6%-110.5%-433.1%-1441.6%-461.4%-101.2%-46.1%-44.2%17.2%-120.7%-91.3%-344.8%
FCF Margin-47.8%-120.4%-44.9%-35.7%-99.4%-425.6%-1,422.7%-377.0%-96.0%-29.6%18.7%-15.2%-157.0%-117.3%285.9%
Effective Tax Rate-----------0.3%---
EBITDA-10.98-9.59-6.28-7.31-13.04-18.81-14.96-15.73-6.68-4.66-3.833.08-7.81-5.21-5.21
EBITDA Margin-110.6%-145.3%-50.2%-40.1%-109.6%-429.3%-1419.4%-452.3%-96.2%-42.3%-39.3%19.6%-116.2%-88%-340%
EBIT-11.03-9.65-6.54-7.40-13.15-18.97-15.19-16.04-7.03-5.08-4.262.70-8.11-5.39-5.29
EBIT Margin-111.1%-146.3%-52.3%-40.6%-110.5%-433.0%-1,441.4%-461.3%-101.1%-46.1%-43.7%17.2%-120.7%-91.1%-344.8%

Showing 15 of 17 years

2 more years are available